China’s National Medical Products Administration (NMPA) is setting up a centralized unit for the standardization of medical high-throughput sequencing technology.
In disclosing the plan, NMPA published a document detailing the intent to address standards related to reference genomes, reagents, data analysis software, tumor diagnosis and other areas involved in the medical applications of sequencing technology. NMPA is yet to provide exact details of what the unit will do and over what timeline.
The rest of the document lists the 76 people and organizations involved in the initiative. The list features people working in academia, healthcare and industry alongside representatives of Chinese regulatory agencies.
To continue reading this article please go to NMPA .